Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease caused by progressive loss of upper and lower motor neurons in the brain, brainstem, and spinal cord. It presents as painless muscle weakness that starts either in the limbs (spinal onset) or in the muscles of speech and swallowing (bulbar onset), and then spreads to other body regions Goutman SA et al. (2022). Most patients die from respiratory failure within a 2-5 years of diagnosis. A pathological hallmark is the aggregation of the protein TDP-43 in affected neurons. Most cases are sporadic, while 5–10% are familial, with mutations in genes such as C9orf72, SOD1, TARDBP, and FUS. ALS overlaps clinically and genetically with frontotemporal dementia, and many patients develop cognitive or behavioural changes Feldman EL et al. (2022).

Differential abundance and machine learning analysis

This section presents the disease-specific results of the differential abundance and machine learning analyses. The analyses are reported for three comparisons: 1) disease vs. all other diseases, 2) disease vs. diseases from the same class, and 3) disease vs. healthy samples.

DIFFERENTIAL ABUNDANCE AND MACHINE LEARNING ANALYSIS
Technology
Olink Explore HT
SomaScan 11K
Comparison
Disease vs All other
Disease vs Class
Disease vs Healthy

COMPARE TECHNOLOGIES FOR THIS DISEASE
Fold change per technology · most differentially abundant proteins across technologies ·
Concordance: Olink HT vs SomaScan ·